AI assistant
EQUIFAX INC — Director's Dealing 2025
Jul 30, 2025
30136_dirs_2025-07-30_d97568ad-cb20-467e-be48-2987d24827bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2025-07-28
Reporting Person: Begor Mark W (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-28 | Common Stock | M | 27960.0000 | $191.4400 | Acquired | 191136.0000 | Direct |
| 2025-07-28 | Common Stock | S | 364.0000 | $244.9479 | Disposed | 190772.0000 | Direct |
| 2025-07-28 | Common Stock | S | 831.0000 | $243.9032 | Disposed | 189941.0000 | Direct |
| 2025-07-28 | Common Stock | S | 9497.0000 | $242.7014 | Disposed | 180444.0000 | Direct |
| 2025-07-28 | Common Stock | S | 17731.0000 | $241.8713 | Disposed | 162713.0000 | Direct |
| 2025-07-28 | Common Stock | S | 19841.0000 | $240.9462 | Disposed | 142872.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-28 | Stock Option/Right to Buy | $191.4400 | M | 27960.0000 | Disposed | 2026-02-21 | Common Stock (27960.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10500.0000 | Indirect |
| Common Stock | 9525.0000 | Indirect |
| Common Stock | 11380.0000 | Indirect |
| Common Stock | 43431.0000 | Indirect |
| Common Stock | 12333.0000 | Indirect |
| Common Stock | 16287.0000 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
F2: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F3: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F4: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F8: The option vested in three equal annual increments beginning 2/21/2021.